Immediate Impact
56 standout
Citing Papers
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
The interaction of innate immune and adaptive immune system
2024 Standout
Works of Patti Byron being referenced
Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
2014 Standout
Gemtuzumab Ozogamicin (GO) In Children With De Novo Acute Myeloid Leukemia (AML) Improves Event-Free Survival (EFS) By Reducing Relapse Risk – Results From The Randomized Phase III Children’s Oncology Group (COG) Trial, AAML0531
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Patti Byron | 259 | 111 | 143 | 126 | 8 | 353 | |
| Kathleen Glick | 273 | 115 | 153 | 129 | 9 | 371 | |
| JN Winter | 283 | 151 | 95 | 76 | 11 | 401 | |
| AC Homans | 140 | 119 | 139 | 72 | 12 | 317 | |
| G. J. Dovey | 127 | 163 | 148 | 72 | 10 | 366 | |
| A Nandi | 318 | 155 | 56 | 167 | 11 | 391 | |
| M. M. A. Rottier | 99 | 175 | 177 | 149 | 9 | 386 | |
| Henrik Schr�der | 149 | 93 | 232 | 58 | 13 | 369 | |
| G. Zeile | 366 | 104 | 106 | 84 | 6 | 409 | |
| AT Look | 178 | 122 | 212 | 98 | 8 | 350 | |
| G Prentice | 207 | 70 | 61 | 103 | 12 | 378 |
All Works
Loading papers...